Document Detail


Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence.
MedLine Citation:
PMID:  23614675     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This review examines the growing literature on the role of peroxisome proliferator-activated receptors (PPARs) in addiction. There are two subtypes of PPAR receptors that have been studied in addiction: PPAR-α and PPAR-γ. The role of each PPAR subtype in common models of addictive behavior, mainly pre-clinical models, is summarized. In particular, studies are reviewed that investigated the effects of PPAR-α agonists on relapse, sensitization, conditioned place preference, withdrawal and drug intake, and effects of PPAR-γ agonists on relapse, withdrawal and drug intake. Finally, studies that investigated the effects of PPAR agonists on neural pathways of addiction are reviewed. Taken together these preclinical data indicate that PPAR agonists are promising new medications for drug addiction treatment.
Authors:
Bernard Le Foll; Patricia Di Ciano; Leigh V Panlilio; Steven R Goldberg; Roberto Ciccocioppo
Related Documents :
23754165 - In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the...
23995265 - Practicability of pharmacogenetics in transplantation medicine.
24041355 - Treatment dynamics of newly marketed drugs and implications for comparative effectivene...
24734245 - Digging up the human genome: current progress in deciphering adverse drug reactions.
17524245 - Detection of in-vivo chloroquine resistance in plasmodium falciparum from rameswaram is...
24918565 - Systematic review of vismodegib toxicity profile in the treatment of advanced basal cel...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural; Review    
Journal Detail:
Title:  Current drug targets     Volume:  14     ISSN:  1873-5592     ISO Abbreviation:  Curr Drug Targets     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-05-24     Completed Date:  2013-12-27     Revised Date:  2014-06-03    
Medline Journal Info:
Nlm Unique ID:  100960531     Medline TA:  Curr Drug Targets     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  768-76     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Drug Design
Drug Evaluation, Preclinical
Humans
PPAR alpha / agonists*,  metabolism
PPAR gamma / agonists*,  metabolism
Recurrence / prevention & control
Substance Withdrawal Syndrome / drug therapy,  physiopathology
Substance-Related Disorders / drug therapy*,  physiopathology
Grant Support
ID/Acronym/Agency:
Z99 DA999999/DA/NIDA NIH HHS; ZIA DA000001-28/DA/NIDA NIH HHS; ZIA DA000003-27/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/PPAR alpha; 0/PPAR gamma
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Accuracy of infrared thermometers in very low birth weight infants and impact on newborn behavioural...
Next Document:  Yeast as a Biosensor of Detoxification: A Tool For Identifying New Compounds That Revert Multidrug R...